Over 90% of the drugs that appear safe and effective in animals do not receive FDA clearance for humans.
In April 2025, the United States Food and Drug Administration announced a Roadmap to Reducing Animal Testing in Preclinical Safety Studies.
The FDA intends to reduce and phase out animal testing and promote alternatives such as organoids and organ-on-a-chip systems.
Cell Applications has released a new video about the FDA’s strategy!
Cell Applications provides primary cells and cell culturing products for a wide variety of applications, including organoids and organ-on-a-chip systems.
The organ-on-a-chip microfluidic devices allow cell culture and in-vitro models of organs in compartmentalized 3D structures.
The flows between cell types in different compartments enable real-time and long-term monitoring of the impact of stimuli.
Organoids and Organ-on-a-chip technologies can help transform drug screening and toxicity testing from reliance on animal testing.
Cell Applications also has media, reagents, and supplements for culturing cells for this exciting new innovation frontier.
Visit www.cellapplications.com for products to supercharge your experiments and research.
No Comments yet!